IL-33–activated dendritic cells induce an atypical TH2-type response
Matthew A. Rank(Mayo Clinic in Arizona), Hirohito Kita(Mayo Clinic), Takao Kobayashi(Hokkaido University), Hideaki Kozaki(Mayo Clinic), Kathleen R. Bartemes(Mayo Clinic), Diane L. Squillace(Mayo Clinic)
Cited by 400
Related Papers
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|690
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|552
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|533
The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses
|The Journal of Immunology|2011|490
Rhinitis 2020: A practice parameter update
|Journal of Allergy and Clinical Immunology|2020|420